![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » GLUCON GLUCOSE MONITOR IN CLINICAL TRIALS
GLUCON GLUCOSE MONITOR IN CLINICAL TRIALS
July 27, 2006
Sources inform ''Globes'' that Glucon Inc.'s prototype device for alerting hyperglycemia (high blood sugar) in hospitalized patients is conducting clinical trials. The company has kept quiet about the device until now, disclosing no details about it. It now turns out that the company's device reached clinical trials without the market being aware of it. Globes Online (http://www.globes.co.il/serveen/globes/DocView.asp?did=1000116806&fid=1725)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct